Skip to main content

Purslane

Scientific Name(s): Portulaca oleracea L.
Common Name(s): Garden (common) purslane, Gelang pasir, Little hogweed, Ma Chi Xian, Munyeroo, Pigweed, Portulaca, Pourpier, Purslane, Pusley, Pussly, Rigla, Sormai

Medically reviewed by Drugs.com. Last updated on Dec 1, 2022.

Clinical Overview

Use

Purslane has been used as a vegetable source of omega-3 fatty acids and is high in vitamins and minerals. Purslane possesses anti-inflammatory activity. Roles in asthma, dyslipidemia, constipation, and type 2 diabetes, among other conditions, have been suggested; however, clinical studies are limited.

Dosing

Limited clinical studies are available to provide dosage guidelines, with various dosages and preparations evaluated. See specific indications in Uses and Pharmacology section.

Contraindications

Contraindications have not been identified.

Pregnancy/Lactation

Avoid use. Information regarding safety and efficacy in pregnancy and lactation is lacking.

Interactions

None well documented.

Adverse Reactions

Limited clinical studies have not reported significant adverse effects. Constipation has been reported.

Toxicology

No data.

Scientific Family

Botany

The purslane family includes several fleshy plants. P. oleracea is an herbaceous, succulent annual that grows 10 to 30 cm in height and prefers sandy soil and warmer conditions. It is sometimes considered a weed because of its invasive growth patterns. The plant has reddish-brown stems, alternate wedge-shaped leaves, clusters of yellow flowers containing 4 to 6 petals that bloom in summer, and numerous black, shiny, and rough seeds. The botanical name is derived from the Latin potare (meaning "to carry") and lac (or "milk," referring to the milky sap of the plant). Synonyms are Portulaca neglecta Mack. & Bush and Portulaca retusa Engelm. P. oleracea (also known as little hogweed) should not be confused with giant hogweed (Heracleum mantegazzianum).(Chevallier 1996, Rashed 2003, USDA 2022)

History

In ancient times, purslane was used to protect against evil spirits. Purslane has been used medicinally for at least 2,000 years but was used as food well before this period. Traditional medicinal uses for purslane are broad. Ancient Romans used purslane to treat dysentery, intestinal worms, headache, and stomachache. Purslane has also been used for thousands of years in traditional Chinese medicine and is referred to as the "vegetable for long life." Aerial parts are dried and used for fever, diarrhea, carbuncle, eczema, and hematochezia.(Zhou 2015) Other uses in traditional Chinese medicine include for diabetes, atherosclerosis, vascular endothelial dysfunction, and urolithiasis.(Sabzghabaee 2014) Purslane is also used as a food source in various European regions.(Chevallier 1996, D'Amelio 1999)

Chemistry

Various studies have shown that purslane is a rich source of important phytochemicals such as flavonoids; alkaloids (including oleraceins, dopa, dopamine, and noradrenaline); terpenoids; proteins; carbohydrates; vitamins such as A, B, C, and E; carotenoids; and minerals such as phosphorus, calcium, magnesium, and zinc. Purslane contains high concentrations of omega-3 fatty acids, especially alpha-linolenic acid, gamma-linolenic acid, and linoleic acid, which are not generally synthesized in terrestrial plants.(Kumar 2021, Zhou 2015) Antioxidants, including tocopherol, ascorbic acid, beta carotene, and glutathione, are also present.(Ezekwe 1999, Guil-Guerrero 1999, Liu 2000, Simopoulos 2005, Teixeira 2010) The alpha-linolenic acid content varies with cultivar, geography, and environmental factors, with the leaves containing a greater percentage than the seeds and stems.(Palaniswamy 2000, Teixeira 2010) Purslane's bright yellow flowers are of interest in the food industry because of their nitrogen-containing betalain pigments.(Gandía-Herrero 2009, Wang 2010)

Purslane also contains lipids, glycosides, sterols, coumarins, and triterpenes.(Chen 2010, Dong 2010, Xiang 2005, Yang 2009) Phenolic constituents of purslane include scopoletin, bergapten, isopimpinellin, lonchocarpic acid, robustin, genistein, and others.(Aljeboori 2014, Awad 1994) Amino acids in the leaves of the Portulaca species include phenylalanine, alanine, tyrosine, and aspartate.(Mirajkar 1984) Plant acids include isoleucine, proline, leucine, lysine, phenylalanine, methionine, cystine, valine, threonine, and tyrosine.(Zhou 2015) The volatile oil of P. oleracea has also been studied and contains mainly linalool and 3,7,11,15-tetramethyl-2-hexadecen-1-ol.(Liu 1994)

Uses and Pharmacology

Various parts of purslane are known for ethnomedicinal and pharmacological uses because of various associated activities (eg, anti-inflammatory, antidiabetic, skeletal muscle relaxant, hepatoprotective, anticancer/antitumor, antioxidant, gastroprotective, neuroprotective, wound healing).(Kumar 2021)

Anti-inflammatory effects

In vitro data

P. oleracea (gelang pasir) crude extract at concentrations of 250 mcg/mL exhibited potent anti-inflammatory activity in vitro.(Abu Bakar 2018) Similarly, methanol and dichloromethane seed extracts of P. oleracea inhibited gene expression of cyclooxygenase (COX)1, COX2, and prostaglandin E2 enzymes, whereas the methanol extract inhibited tumor necrosis factor (TNF)-alpha and IL-1beta cytokines and the dihloromethane extract upregulated TNF-alpha levels and the anti-inflammatory cytokine IL-10, but exhibited no effect on IL-1beta.(Ahmed 2022)

Clinical data

A systematic review and meta-analysis of randomized controlled trials (10 studies; sample size per study ranged from 14 to 98) in patients with various clinical conditions (eg, metabolic syndrome, aphthous stomatitis, nonalcoholic fatty liver disease, type 2 diabetes), showed a positive effect of purslane supplementation for decreasing C-reactive protein levels. However, biomarkers of oxidative stress remained unchanged.(Zhu 2021)

Antimicrobial/Antiviral effects

In vitro data

Purslane has been reported to possess antifungal, vermicidal, and antiviral effects.(Awad 1994, Dong 2010, Oh 2000)

Antioxidant

In vivo data

Both a pure methanol extract and a dichloromethane oil extract of P. oleracea seeds demonstrated antioxidant activities with different activities observed in different assays.(Ahmed 2022)

Cancer

Animal and in vitro data

In vitro studies have demonstrated activity against human hepatoma and cervical cancer cell lines.(Chen 2010) P. oleracea extract has also been observed to inhibit the development of colorectal cancer in mice in a dose-dependent manner and increase survival. Elucidated mechanisms included 20 potential targets that result from differential gut microbiota in cancer samples versus controls and their effect on a specific signaling pathway.(Yi 2022)

CNS effects

Animal and in vitro data

CNS effects of both ethanol and aqueous extracts of purslane are attributed in part to observed antioxidant activity. Both histological and biochemical studies have shown free radical–scavenging activity, as well as reduced lipid peroxidation, lactate dehydrogenase, and consequent reduced oxidative stress.(Arruda 2004, Boğa 2011, Yang 2009, YouGuo 2009) Other proposed mechanisms include increased glycolysis and adenosine triphosphate levels and promotion of endogenous erythropoietin.(Chen 2009, Wanyin 2012) Experimental studies report levels of noradrenaline and dopamine in the leaves, stems, and seeds of less than 1%, but no anticholinesterase activity for either ethanol or water extracts.(Boğa 2011, Chen 2003)

Limited experiments suggest ethanol extracts and betacyanins from P. oleracea have neuroprotective effects against induced hypoxic injury in mice. Cognition improved and anxiety was reduced in behavioral tests, and histology and biochemical measurements showed neuroprotective properties.(Hongxing 2007, Wang 2007, Wang 2010, Wanyin 2012)

Constipation

Clinical data

In a clinical trial of patients with chronic constipation (N=60), 480 mg daily of an alcoholic purslane extract for 8 weeks significantly increased bowel frequency and improved bowel function and quality of life measures compared with placebo.(Bang 2022) It should be noted that constipation has been reported as a frequent adverse effect in other studies, including in a review of traditional uses, phytochemistry, and pharmacology of P. oleracea.(Iranshahy 2017, Wainstein 2016)

Diabetes

Clinical data

A small clinical trial (N=30) evaluated the effect of purslane seeds in type 2 diabetes. After 8 weeks of 5 g of P. oleracea seeds twice daily, improvements in serum insulin and triglycerides were noted, as well as improvements in liver function tests.(El-Sayed 2011) The efficacy of purslane extract in achieving glucose control in adults with type 2 diabetes was evaluated in a 12-week, double-blind, randomized, placebo-controlled trial (N=63). Purslane extract was dosed at 180 mg/day, which corresponded to 750 mg of dried purslane or 15 g of fresh herb per day. This dose was chosen in order not to exceed commonly ingested quantities of purslane as food, and it was in line with a recommended dosage of 10 to 30 g/day described in a Chinese herbal medicine text. No significant improvement was seen in glucose control overall. However, in a subgroup of "responders" (defined as those with week 12 hemoglobin A1c [HbA1c] that was lower than baseline values), a statistically significant improvement in HbA1c was observed in those who received purslane. Responders treated with biguanides before study enrollment demonstrated a significantly greater change in HbA1c when treated with purslane compared with placebo. Purslane was well tolerated, with constipation listed as the only adverse event.(Wainstein 2016) A review highlighted 12 clinical studies in patients with type 2 diabetes, as well as in vitro and animal data, that support the potential efficacy of purslane in the treatment of metabolic syndrome and its complications. Beneficial effects demonstrated in clinical trials in patients with type 2 diabetes are summarized for purslane seed powder, seed extract, and freeze-dried supplements for reducing fasting blood glucose, hypertension, dyslipidemia, and obesity.(Jalali 2022)

As a component of medical nutrition therapy for patients with type 1 or type 2 diabetes, the American Diabetes Association Standards of Care (2022) recommend an increase in foods containing alpha-linolenic acid to improve lipid profiles and reduce the risk of developing atherosclerotic cardiovascular disease.(ADA 2022)

Dyslipidemia

Clinical data

A triple-blind, randomized, placebo-controlled trial was conducted in adolescents with dyslipidemia and BMI equal to or greater than age- and gender-specific 95th percentile (N=74) to determine the effects of purslane seeds (500 mg twice daily for 1 month) on lipid parameters. Purslane was standardized to a total phenolics equivalent of approximately 1.8 mg of gallic acid. After 1 month, significant improvements from baseline were observed with purslane in LDL cholesterol (−11 mg/dL; P<0.001) and triglycerides (−16 mg/dL; P=0.006). No adverse effects were reported.(Sabzghabaee 2014)

A systematic review and meta-analysis suggested that purslane might be effective in improving blood lipid and glucose levels. However, types of purslane supplementation and daily dosages varied among studies; further robust studies with sufficient durations and supplementation dosages are needed to confirm results.(Hadi 2019)

Fatty acid profile/cholesterol effects

Animal data

Studies in chickens fed purslane have shown improved feed efficiency, with reduced body weight and increased egg production. The cholesterol content of the eggs did not change, but omega-3 fatty acid content increased.(Aydin 2010)

Gastric ulcer

Animal data

Experiments in mice showed reduced severity of induced gastric ulcers with ethanol and aqueous leaf extracts.(Karimi 2004)

Hepatoprotective effects

In vitro data

In vitro studies have demonstrated hepatoprotective effects against cisplatin-induced injury.(Sudhakar 2010)

Clinical data

In a randomized, double-blind clinical trial (N=74) in patients with nonalcoholic fatty liver disease, purslane extract 300 mg/day for 12 weeks had no significant effects on liver enzymes, lipid profile, or glycemic indices.(Darvish Damavandi 2021)

Immunomodulatory effects

In vitro data

In in vitro studies, purslane polysaccharides increased proliferation of thymocytes and splenic lymphocytes.(YouGuo 2009)

Melatonin levels

Animal data

Circulating levels of melatonin were increased in chickens and rats fed purslane.(Simopoulos 2005)

Oral lichen planus

Clinical data

In a small randomized, double-blind, placebo-controlled study of patients with oral lichen planus (N=37), oral purslane extract 235 mg/day for 3 months resulted in better improvements than placebo. According to visual analog scores, a partial to complete response was observed in all purslane-treated patients, while 71%, 15%, and 14% of the controls demonstrated partial response, no response, and worsening of the symptoms, respectively.(Agha-Hosseini 2010)

Pulmonary/Bronchodilator effects

Clinical data

A small clinical trial in patients with asthma (N=13) compared the bronchodilatory effect of an oral boiled purslane 5% extract (dosage of 0.25 mL/kg of body weight) with that of oral theophylline and inhaled salbutamol. Purslane extract showed improvements in pulmonary function tests similar to those of theophylline.(Malek 2004) These findings were supported by a review in which P. oleracea extracts and quercetin showed relatively potent antiasthmatic effects.(Khazdair 2019) Another review showed evidence that purslane has smooth muscle–relaxant properties (bronchodilator effects) via stimulation of beta-adrenoceptor or inhibition of muscarinic receptors (in vitro), with improvement in the pulmonary function test observed in clinical settings. The authors suggested that there may be a place for purslane in the treatment of chronic cough in children.(Mortazavi Moghaddam 2020)

Uterine bleeding

Clinical data

In a small study of premenopausal patients with abnormal uterine bleeding (N=10), reductions in duration and volume of bleeding were observed with purslane seed powder 5 g (administered in a glass of water every 4 hours 48 hours after onset of menstruation for 3 days).(Shobeiri 2009) Based on estrogenic and antiproliferative activity demonstrated in vitro, the effect of P. oleracea seeds on abnormal uterine bleeding was explored among 30 women enrolled in an open, observational trial. The women were 18 to 45 years of age with heavy irregular and abnormal bleeding for at least 3 months. After 2 months of supplementation with purslane seed powder (2 g taken 3 times daily for the first 10 days of 2 consecutive cycles), mean blood loss was significantly reduced during the 1st and 2nd cycles (P<0.001 each) as well as during the 3rd and 4th cycles (P<0.001 each), which were measured at 1 and 2 months post-treatment. Quality of life scores were also significantly improved after the intervention (P<0.001). No significant changes were noted in mean hemoglobin and no adverse events or drop outs were observed.(Khanam 2021)

Wound healing

Animal data

Experiments in mice showed increased wound healing rates with topical applications of crude fresh plant extracts.(Rashed 2003)

Clinical data

In one clinical trial (N=86), purslane cream (2% w/w) was associated with a faster recovery process for nipple fissure healing in lactating women.(Niazi 2019)

Dosing

100 g of fresh purslane leaves yields approximately 300 to 400 mg of alpha-linolenic acid.(Simopoulos 2005)

Limited clinical studies are available to provide dosage guidelines; the following dosages have been used in small clinical trials:

Abnormal uterine bleeding

Purslane seed powder 5 g (administered in a glass of water every 4 hours 48 hours after onset of menstruation for 3 days) was used in one very small study of patients with abnormal uterine bleeding.(Shobeiri 2009)

Bronchodilation

One clinical study evaluated an oral boiled purslane 5% extract (dosage of 0.25 mL/kg of body weight) in patients with asthma.(Malek 2004)

Dyslipidemia (adolescents)

A study of adolescents with dyslipidemia and BMI equal to or greater than age- and gender-specific 95th percentile evaluated the effects of purslane seeds 500 mg twice daily for 1 month on lipid parameters.(Sabzghabaee 2014)

Oral lichen planus

Oral purslane extract 235 mg/day for 3 months was used in a study of patients with oral lichen planus.(Agha-Hosseini 2010)

Type 2 diabetes

One study evaluated 5 g of P. oleracea powdered seeds twice daily over 8 weeks.(El-Sayed 2011) In another study of patients with type 2 diabetes, purslane extract 180 mg/day (equivalent to 750 mg/day of dried herb or 15 g/day of fresh herb) was given for 12 weeks.(Wainstein 2016)

Pregnancy / Lactation

Avoid use. Information regarding safety and efficacy in pregnancy and lactation is lacking. Effects on uterine contractions are contradictory and poorly evaluated; caution is warranted.(El-Sayed 2011, Shobeiri 2009)

Interactions

None well documented.

Adverse Reactions

No clinically important adverse events have been reported with purslane in the limited clinical trials.(Agha-Hosseini 2010, El-Sayed 2011, Malek 2004, Shobeiri 2009) Constipation was reported as the most frequent adverse effect.(Iranshahy 2017) Older references suggest increases in kidney filtration rates and increased urine production, but these events have not been further evaluated.(El-Sayed 2011) Oxalate nephropathy has been reported in an individual consuming large amounts of purslane.(Cai 2022)

Toxicology

Studies are lacking. A toxicology study of Portulaca grandiflora Hook, a related species, found no evidence of toxicity on histology, hematology, or biochemistry.(Chavalittumrong 2004)

Index Terms

References

Disclaimer

This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

Abu Bakar FI, Abu Bakar MF, Abdullah N, Endrini S, Rahmat A. A review of Malaysian medicinal plants with potential anti-inflammatory activity. Adv Pharmacol Sci. 2018;2018:8603602. doi:10.1155/2018/860360230123256
Agha-Hosseini F, Borhan-Mojabi K, Monsef-Esfahani HR, Mirzaii-Dizgah I, Etemad-Moghadam S, Karagah A. Efficacy of purslane in the treatment of oral lichen planus. Phytother Res. 2010;24(2):240-244. doi:10.1002/ptr.291919585472
Ahmed SA, Shaker SE, Shawky H. Solvent polarity dictates the anti-inflammatory potency and mechanism of two purslane (Portulaca oleracea) seed extracts. J Food Biochem. 2022;46(10):e14281. doi:10.1111/jfbc.1428135735134
Aljeboori KH, AL-Rubai OHK, Yassen NY. Study of pathological effects of crude extract of Portulaca oleracea L. in the albino mice organs. Int J Tech Res Appl. 2014;2(1):29-32.
American Diabetes Association. Standards of medical care in diabetes--2022. Diabetes Care. 2022;45(suppl 1):S1-S264.
Arruda SF, Siqueira EM, Souza EM. Malanga (Xanthosoma sagittifolium) and purslane (Portulaca oleracea) leaves reduce oxidative stress in vitamin A-deficient rats. Ann Nutr Metab. 2004;48(4):288-295. doi:10.1159/00008107515452401
Awad N. Lipid content and antimicrobial activity of phenolic constituents of cultivated Portulaca oleracea L. Bull Fac Pharm. 1994;32:137-142.
Aydin R, Dogan I. Fatty acid profile and cholesterol content of egg yolk from chickens fed diets supplemented with purslane (Portulaca oleracea L.). J Sci Food Agric. 2010;90(10):1759-1763. doi:10.1002/jsfa.401820564433
Bang KB, Choi JH, Park JH, et al. Effect of Portulaca oleracea L. extract on functional constipation: a randomized, double-blind, placebo-controlled trial. Saudi J Gastroenterol. 2022;28(4):296-303. doi:10.4103/sjg.sjg_400_2135848700
Boğa M, Hacıbekiroğlu I, Kolak U. Antioxidant and anticholinesterase activities of eleven edible plants. Pharm Biol. 2011;49(3):290-295. doi:10.3109/13880209.2010.51753921284538
Cai DH, Fang XL. Portulaca oleracea-associated oxalate nephropathy complicated with an ANCA-positive acute renal injury: a case report. Transpl Immunol. Published online March 25, 2022. doi:10.1016/j.trim.2022.10158935346825
Chavalittumrong P, Chivapat S, Attawish A, et al. Chronic toxicity study of Portulaca grandiflora Hook. J Ethnopharmacol. 2004;90(2-3):375-380. doi:10.1016/j.jep.2003.10.01815013204
Chen CJ, Wang WY, Wang XL, et al. Anti-hypoxic activity of the ethanol extract from Portulaca oleracea in mice. J Ethnopharmacol. 2009;124(2):246-250. doi:10.1016/j.jep.2009.04.02819397978
Chen J, Shi YP, Liu JY. Determination of noradrenaline and dopamine in Chinese herbal extracts from Portulaca oleracea L. by high-performance liquid chromatography. J Chromatogr A. 2003;1003(1-2):127-132. doi:10.1016/s0021-9673(03)00786-612899302
Chen T, Wang J, Li Y, Shen J, Zhao T, Zhang H. Sulfated modification and cytotoxicity of Portulaca oleracea L. polysaccharides. Glycoconj J. 2010;27(6):635-642. doi:10.1007/s10719-010-9307-020820911
Chevallier A. The Encyclopedia of Medicinal Plants: A Practical Reference Guide to Over 550 Key Herbs and their Medicinal Uses. DK Publishing; 1996:253.
D'Amelio F. Botanicals: A Phytocosmetic Desk Reference. CRC Press; 1999:245-246.
Darvish Damavandi R, Shidfar F, Najafi M, et al. Effect of Portulaca oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: a randomized, double-blind clinical trial. Phytother Res. 2021;35(6):3145-3156. doi:10.1002/ptr.697233880813
Dong CX, Hayashi K, Lee JB, Hayashi T. Characterization of structures and antiviral effects of polysaccharides from Portulaca oleracea L. Chem Pharm Bull (Tokyo). 2010;58(4):507-510. doi:10.1248/cpb.58.50720410633
El-Sayed MI. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol. 2011;137(1):643-651. doi:10.1016/j.jep.2011.06.02021718775
Ezekwe MO, Omara-Alwala TR, Membrahtu T. Nutritive characterization of purslane accessions as influenced by planting date. Plant Foods Hum Nutr. 1999;54(3):183-191. doi:10.1023/a:100810162038210716400
Gandía-Herrero F, Jiménez-Atiénzar M, Cabanes J, Escribano J, García-Carmona F. Fluorescence detection of tyrosinase activity on dopamine-betaxanthin purified from Portulaca oleracea (common purslane) flowers. J Agric Food Chem. 2009;57(6):2523-2528. doi:10.1021/jf803608x19227976
Guil-Guerrero J, Rodríguez-Garcia I. Lipids classes, fatty acids, and carotenes of the leaves of six edible wild plants. Z Lebensm Unters Forsch A. 1999;209(5):313-316.
Hadi A, Pourmasoumi M, Najafgholizadeh A, Kafeshani M, Sahebkar A. Effect of purslane on blood lipids and glucose: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(1):3-12. doi:10.1002/ptr.620330281177
Hongxing Z, Nancai Y, Guofu H, et al. Neuroprotective effects of purslane herb aquenous extracts against D-galactose induced neurotoxicity. Chem Biol Interact. 2007;170(3):145-152. doi:10.1016/j.cbi.2007.07.00917764668
Iranshahy M, Javadi B, Iranshahi M, et al. A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L. J Ethnopharmacol. 2017;205:158-172. doi:10.1016/j.jep.2017.05.00428495602
Jalali J, Ghasemzadeh Rahbardar M. Ameliorative effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: A review. J Ethnopharmacol. 2022;299:115672. doi:10.1016/j.jep.2022.11567236064150
Karimi G, Hosseinzadeh H, Ettehad N. Evaluation of the gastric antiulcerogenic effects of Portulaca oleracea L. extracts in mice. Phytother Res. 2004;18(6):484-487. doi:10.1002/ptr.146315287075
Khanam B, Begum W, Tipo FA, Naim M. Effect of Tukhme Khurfa (Purslane seeds) in abnormal uterine bleeding: a prospective study. Adv Integr Med. 2021;8:193-198. doi.org/10.1016/j.aimed.2020.03.001
Khazdair MR, Anaeigoudari A, Kianmehr M. Anti-asthmatic effects of Portulaca oleracea and its constituents, a review. J Pharmacopuncture. 2019;22(3):122-130. doi:10.3831/KPI.2019.22.01631673441
Kumar A, Sreedharan S, Kashyap AK, Singh P, Ramchiary N. A review on bioactive phytochemicals and ethnopharmacological potential of purslane (Portulaca oleracea L.). Heliyon. 2021;8(1):e08669. doi:10.1016/j.heliyon.2021.e0866935028454
Liu L, Howe P, Zhou YF, Xu ZQ, Hocart C, Zhan R. Fatty acids and beta-carotene in Australian purslane (Portulaca oleracea) varieties. J Chromatogr A. 2000;893(1):207-213. doi:10.1016/s0021-9673(00)00747-011043602
Liu P, et al. GC-MS analysis of volatile oil of Portulaca oleracea. L. Ziran Kexueban 1994;14:72-74.
Malek F, Boskabady MH, Borushaki MT, Tohidi M. Bronchodilatory effect of Portulaca oleracea in airways of asthmatic patients. J Ethnopharmacol. 2004;93(1):57-62. doi:10.1016/j.jep.2004.03.01515182905
Mirajkar P, et al. Studies on leaf protein of Portulaca species and other leafy vegetables. Curr Trends Life Sci. 1984;11(Prog. Leaf Protein res.):95-98.
Mortazavi Moghaddam SG, Kianmehr M, Khazdair MR. The possible therapeutic effects of some medicinal plants for chronic cough in children. Evid Based Complement Alternat Med. 2020;2020:2149328. doi:10.1155/2020/214932833062002
Niazi A, Yousefzadeh S, Rakhshandeh H, Esmaily H, Askari VR. Promising effects of purslane cream on the breast fissure in lactating women: a clinical trial. Complement Ther Med. 2019;43:300-305. doi:10.1016/j.ctim.2019.02.00230935548
Oh KB, Chang IM, Hwang KJ, Mar W. Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system. Phytother Res. 2000;14(5):329-332. doi:10.1002/1099-1573(200008)14:5<329::aid-ptr581>3.0.co;2-510925396
Palaniswamy U, et al. Omega-3 fatty acid concentration in Portulaca oleracea is altered by nitrogen source in hydroponic solution. J Am Soc Hortic Sci. 2000;125:190-194.
Portulaca L. USDA, NRCS. 2022. The PLANTS Database (http://plants.usda.gov, 18 October 2022). National Plant Data Team, Greensboro, NC 27401–4901 USA.
Rashed AN, Afifi FU, Disi AM. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J Ethnopharmacol. 2003;88(2-3):131-136. doi:10.1016/s0378-8741(03)00194-612963132
Sabzghabaee AM, Kelishadi R, Jelokhanian H, Asgary S, Ghannadi A, Badri S. Clinical effects of Portulaca oleracea seeds on dyslipidemia in obese adolescents: a triple-blinded randomized controlled trial. Med Arch. 2014;68(3):195-199. doi:10.5455/medarh.2014.68.195-19925568533
Shobeiri SF, Sharei S, Heidari A, Kianbakht S. Portulaca oleracea L. in the treatment of patients with abnormal uterine bleeding: a pilot clinical trial. Phytother Res. 2009;23(10):1411-1414. doi:10.1002/ptr.279019274703
Simopoulos AP, Tan DX, Manchester LC, Reiter RJ. Purslane: a plant source of omega-3 fatty acids and melatonin. J Pineal Res. 2005;39(3):331-332. doi:10.1111/j.1600-079X.2005.00269.x16150116
Sudhakar D, Krishna Kishore R, Parthasarathy PR. Portulaca oleracea L. extract ameliorates the cisplatin-induced toxicity in chick embryonic liver. Indian J Biochem Biophys. 2010;47(3):185-189.20653291
Teixeira MC, Carvalho IS, Brodelius M. Omega-3 fatty acid desaturase genes isolated from purslane (Portulaca oleracea L.): expression in different tissues and response to cold and wound stress. J Agric Food Chem. 2010;58(3):1870-1877. doi:10.1021/jf902684v20070085
Wainstein J, Landau Z, Bar Dayan Y, et al. Purslane extract and glucose homeostasis in adults with type 2 diabetes: a double-blind, placebo-controlled clinical trial of efficacy and safety. J Med Food. 2016;19(2):133-140. doi:10.1089/jmf.2015.009026854844
Wang CQ, Yang GQ. Betacyanins from Portulaca oleracea L. ameliorate cognition deficits and attenuate oxidative damage induced by D-galactose in the brains of senescent mice. Phytomedicine. 2010;17(7):527-532. doi:10.1016/j.phymed.2009.09.00619879120
Wang W, Gu L, Dong L, Wang X, Ling C, Li M. Protective effect of Portulaca oleracea extracts on hypoxic nerve tissue and its mechanism. Asia Pac J Clin Nutr. 2007;16(suppl 1):227-233.17392109
Wanyin W, Liwei D, Lin J, Hailiang X, Changquan L, Min L. Ethanol extract of Portulaca oleracea L. protects against hypoxia-induced neuro damage through modulating endogenous erythropoietin expression. J Nutr Biochem. 2012;23(4):385-391. doi:10.1016/j.jnutbio.2010.12.01521543202
Xiang L, Xing D, Wang W, Wang R, Ding Y, Du L. Alkaloids from Portulaca oleracea L. Phytochemistry. 2005;66(21):2595-2601. doi:10.1016/j.phytochem.2005.08.01116203019
Yang Z, Liu C, Xiang L, Zheng Y. Phenolic alkaloids as a new class of antioxidants in Portulaca oleracea. Phytother Res. 2009;23(7):1032-1035. doi:10.1002/ptr.274219140117
Yi S, Jin X, Liu B, Wu P, Xiao W, Chen W. Portulaca oleracea extract reduces gut microbiota imbalance and inhibits colorectal cancer progression via inactivation of the Wnt/β-catenin signaling pathway. Phytomedicine. 2022;105:154279. doi:10.1016/j.phymed.2022.15427935963192
YouGuo C, ZongJi S, XiaoPing C. Evaluation of free radicals scavenging and immunity-modulatory activities of purslane polysaccharides. Int J Biol Macromol. 2009;45(5):448-452. doi:10.1016/j.ijbiomac.2009.07.00919643128
Zhou YX, Xin HL, Rahman K, Wang SJ, Peng C, Zhang H. Portulaca oleracea L.: a review of phytochemistry and pharmacological effects. Biomed Res Int. 2015;2015:925631. doi:10.1155/2015/92563125692148
Zhu Y, Huang Y, Santos HO, de Oliveira CVC, Zhou H, Tang N. Effects of purslane supplementation on C-reactive protein levels and biomarkers of oxidative stress as marks for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2021;35(10):5477-5486. doi:10.1002/ptr.718234109686

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.